California Capital Equity, LLC (CCE) has injected C$21.05m into ProMetic’s coffers via the exercise of all of its 44.8m outstanding warrants. Encouragingly CCE’s CEO, Dr. Patrick Soon Shiong stated that the “increased equity position in ProMetic represents a long term and strategic investment.” This investment underpins ProMetic’s funding for its busy R&D programme until late 2017. By this time we expect to see further data on multiple programs plus the launc
07 Feb 2017
Long-term backers reaffirm support for ProMetic
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Long-term backers reaffirm support for ProMetic
ProMetic Life Sciences (PLI:TSE) | 0 0 1.3% | Mkt Cap: 1,075m
- Published:
07 Feb 2017 -
Author:
Darshan Patel -
Pages:
6
California Capital Equity, LLC (CCE) has injected C$21.05m into ProMetic’s coffers via the exercise of all of its 44.8m outstanding warrants. Encouragingly CCE’s CEO, Dr. Patrick Soon Shiong stated that the “increased equity position in ProMetic represents a long term and strategic investment.” This investment underpins ProMetic’s funding for its busy R&D programme until late 2017. By this time we expect to see further data on multiple programs plus the launc